{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320531792768.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.transproceed.2010.05.127"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S004113451000792X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S004113451000792X?httpAccept=text/plain"}}],"dc:title":[{"@value":"Efficacy and Safety of Entecavir and/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post–Liver Transplant"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320531792769","@type":"Researcher","foaf:name":[{"@value":"M. Jiménez-Pérez"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320531792773","@type":"Researcher","foaf:name":[{"@value":"A.B. Sáez-Gómez"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320531792768","@type":"Researcher","foaf:name":[{"@value":"L. Mongil Poce"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320531792772","@type":"Researcher","foaf:name":[{"@value":"J.M. Lozano-Rey"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320531792770","@type":"Researcher","foaf:name":[{"@value":"J. de la Cruz-Lombardo"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320531792771","@type":"Researcher","foaf:name":[{"@value":"J.M. Rodrigo-López"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00411345"}],"prism:publicationName":[{"@value":"Transplantation Proceedings"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2010-10","prism:volume":"42","prism:number":"8","prism:startingPage":"3167","prism:endingPage":"3168"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S004113451000792X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S004113451000792X?httpAccept=text/plain"}],"createdAt":"2010-10-22","modifiedAt":"2018-12-07","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185710951808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living‐donor liver transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.transproceed.2010.05.127"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_56WA5VAOCZ1II1UwWjJ9goP27Zc"},{"@type":"CROSSREF","@value":"10.1111/j.1872-034x.2012.01020.x_references_DOI_56WA5VAOCZ1II1UwWjJ9goP27Zc"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_56WA5VAOCZ1II1UwWjJ9goP27Zc"}]}